• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Pressemeddelelse

Obducat receives order for NIL system from the University of Liverpool

Obducat

OBDUCAT has received an order from the University of Liverpool for an EITRE 3 nanoimprint lithography (NIL) system. The order value amounts to approximately SEK 2 million and delivery is planned for the second quarter of 2026.

The EITRE 3 system will be installed at the Magnetic Materials Lab within the Department of Physics at the University of Liverpool. The system will be used in research related to medical imaging, with a focus on developing advanced materials that can support new diagnostic methods within healthcare.

The EITRE 3 system enables the manufacturing of very small and precise structures, which is an important capability in this type of applied research. The order further strengthens Obducat’s position within academic research and advanced development environments.

For further information, please contact:
Henri Bergstrand, Chairman: +46 (0)46-10 16 00 or +46 (0) 708-88 72 45
Patrik Lundström, CEO: +46 (0)46 10 16 00 or +46 (0) 703 27 37 38


About Obducat AB (publ)
Obducat AB (publ) is an innovative developer and supplier of technologies, products and processes used for the production and replication of advanced micro and nano structures. Obducat's products and services serve the demands of customers worldwide within the LED and Display, Optics and Photonics, MEMS and Sensor industries as well as in High Power and High Frequency electronics and Biomedical Devices. Obducat's technologies include nano imprint technology, resist- and wet processing technologies. Obducat has its own market presence in Sweden, Germany, Japan, USA, England, Portugal and China and the headquarter is located in Lund, Sweden. Obducat is a public company. The Obducat share is traded on the Swedish NGM Main Regulated Equity exchange. Read more at www.obducat.com or contact us via email investorrelations@obducat.com


Attachments
Obducat receives order for NIL system from the University of Liverpool